Natalia V. Oreshkova
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Natalia V. Oreshkova has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- A. A. Shalyova
Siberian Federal University; Federal Siberian Scientific Clinical Center
1 shared publication - Diana Viktorovna Dmitrenko
Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
1 shared publication - E. A. Osipova
Voino-Yasenetsky Krasnoyarsk State Medical University
1 shared publication - Elena Aleksandrovna Dunaeva
Central Research Institute of Epidemiology of the Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing
1 shared publication - Elena E. Timechko
Professor V.F. Voino-Yasenetsky Krasnoyarsk State Medical University
1 shared publication - Evgeny Vasilyev
Endocrinology Research Centre
1 shared publication
Latest Publications
- 20 July 2026
- Published by Pleiades Publishing Ltd in Russian Journal of Genetics
Molecular Genetic Markers in the Studies of Conifer Species
Molecular genetic markers (MGMs) are powerful tools that allow researchers to study the population structure, assess the level of genetic variability, track migration processes within the species. The review considers various aspects and effectiveness of using various MGMs for studying the genetic diversity of different conifer species. It provides an analysis of history of MGM development, their classification and characteristics, and examples of MGMs most frequently used in studies of conifer species. Particular attention is given to modern DNA markers developed using next-generation sequencing (NGS) technologies. Genome-wide association studies (GWAS) of important adaptive and breeding-valuable traits across a large number of conifer genes became possible only due to such modern DNA markers. Compared with traditional markers, they provide more comprehensive information on genetic variation in conifer species, allowing researchers to identify associations of genetic variation with variation in such important traits as disease resistance, drought tolerance, growth rate, wood quality, etc., as well as with variation in environmental factors and bioclimatic parameters. It should be noted that in general, the topic of MGMs is vast and covers thousands of publications. Therefore, the development and use of MGMs in the studies on conifers, one of the most important plant groups, is the primary focus of this review. Moreover, the main focus will be on publications on conifers growing in Russia that, in our opinion, still remain insufficiently studied genetically. Therefore, the authors apologize in advance to all researchers, whose worthy publications were not mentioned in this review due to limitations of its permissible volume.
- 20 July 2026
- Published by Pleiades Publishing Ltd in Russian Journal of Genetics
Molecular Genetic Markers in the Studies of Conifer Species
Molecular genetic markers (MGMs) are powerful tools that allow researchers to study the population structure, assess the level of genetic variability, track migration processes within the species. The review considers various aspects and effectiveness of using various MGMs for studying the genetic diversity of different conifer species. It provides an analysis of history of MGM development, their classification and characteristics, and examples of MGMs most frequently used in studies of conifer species. Particular attention is given to modern DNA markers developed using next-generation sequencing (NGS) technologies. Genome-wide association studies (GWAS) of important adaptive and breeding-valuable traits across a large number of conifer genes became possible only due to such modern DNA markers. Compared with traditional markers, they provide more comprehensive information on genetic variation in conifer species, allowing researchers to identify associations of genetic variation with variation in such important traits as disease resistance, drought tolerance, growth rate, wood quality, etc., as well as with variation in environmental factors and bioclimatic parameters. It should be noted that in general, the topic of MGMs is vast and covers thousands of publications. Therefore, the development and use of MGMs in the studies on conifers, one of the most important plant groups, is the primary focus of this review. Moreover, the main focus will be on publications on conifers growing in Russia that, in our opinion, still remain insufficiently studied genetically. Therefore, the authors apologize in advance to all researchers, whose worthy publications were not mentioned in this review due to limitations of its permissible volume.
- Open Access
- 28 December 2023
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 68 (4) , 498-510-510
Analysis of mutations in EPOR, VHL, EPAS1 and EGLN1 genes associated with the familial erythrocytosis ECYT1-4 among JAK2- and CALR-negative patients with the erythrocytosis of unclear etiology
Introduction. In addition to the clonal nature of the development of erythrocytosis, there are other causes, such as germinal mutations in genes of proteins responsible for the development of familial inherited erythrocytosis (EPOR, VHL, EPAS1, EGLN1, etc.).Aim. To conduct the analysis of mutations in the EPOR, VHL, EPAS1 and EGLN1 genes associated with the familial erythrocytosis ECYT1-4 among JAK2- and CALR-negative patients.Materials and methods. The study included 50 JAK2- and CALR-negative patients of Krasnoyarsk Krai with erythrocytosis of unclear etiology. Analysis of mutations in the EPOR, VHL, EPAS1 and EGLN1 genes, responsible for the development of familial erythrocytosis was conducted with the use of the Sanger sequencing. A mass parallel sequencing study was also performed for 12 patients.Results. The Sanger sequencing analysis of EPOR, VHL, EPAS1 and EGLN1 revealed any of the genetic variants in 22 of the 50 patients studied. Of all the variants identifi ed in the coding regions of the genes surveyed that result in amino acid substitutions, the following were of biggest interest: 1) two mutations in the VHL gene (rs28940298 and rs5030821) associated with the development of Chuvash polycythemia (ECYT2); 2) rs12097901 variant in the EGLN1 gene associated with altitude adaptation and increasing haemoglobin levels, but with no pathogenetic relevance for erythrocytosis according to ClinVar; and 3) one mutation in the EPOR gene not previously described in literature. According to the results of the NGS study, 12 somatic and 4 putative germinal variants were identifi ed in 5 out of 12 patients.Conclusion. The possibility of conducting a comprehensive molecular genetic study in order to identify new mutations or those already described in the literature in genes associated with familial erythrocytosis could make a signifi cant contribution to the diagnosis of patients with absolute erythrocytosis.
- 28 December 2023
- Published by National Medical Research Center of Hematology of the Ministry of Health of the Russian Federation in Russian journal of hematology and transfusiology
- Vol. 68 (4) , 498-510-510
Open AccessAnalysis of mutations in EPOR, VHL, EPAS1 and EGLN1 genes associated with the familial erythrocytosis ECYT1-4 among JAK2- and CALR-negative patients with the erythrocytosis of unclear etiology
Introduction. In addition to the clonal nature of the development of erythrocytosis, there are other causes, such as germinal mutations in genes of proteins responsible for the development of familial inherited erythrocytosis (EPOR, VHL, EPAS1, EGLN1, etc.).Aim. To conduct the analysis of mutations in the EPOR, VHL, EPAS1 and EGLN1 genes associated with the familial erythrocytosis ECYT1-4 among JAK2- and CALR-negative patients.Materials and methods. The study included 50 JAK2- and CALR-negative patients of Krasnoyarsk Krai with erythrocytosis of unclear etiology. Analysis of mutations in the EPOR, VHL, EPAS1 and EGLN1 genes, responsible for the development of familial erythrocytosis was conducted with the use of the Sanger sequencing. A mass parallel sequencing study was also performed for 12 patients.Results. The Sanger sequencing analysis of EPOR, VHL, EPAS1 and EGLN1 revealed any of the genetic variants in 22 of the 50 patients studied. Of all the variants identifi ed in the coding regions of the genes surveyed that result in amino acid substitutions, the following were of biggest interest: 1) two mutations in the VHL gene (rs28940298 and rs5030821) associated with the development of Chuvash polycythemia (ECYT2); 2) rs12097901 variant in the EGLN1 gene associated with altitude adaptation and increasing haemoglobin levels, but with no pathogenetic relevance for erythrocytosis according to ClinVar; and 3) one mutation in the EPOR gene not previously described in literature. According to the results of the NGS study, 12 somatic and 4 putative germinal variants were identifi ed in 5 out of 12 patients.Conclusion. The possibility of conducting a comprehensive molecular genetic study in order to identify new mutations or those already described in the literature in genes associated with familial erythrocytosis could make a signifi cant contribution to the diagnosis of patients with absolute erythrocytosis.
- Open Access
- 15 October 2022
- Published by IRBIS in Epilepsy and paroxysmal conditions
- Vol. 14 (3) , 254-266
Whole-exome sequencing of patients with juvenile myoclonic epilepsy
Background. Juvenile myoclonic epilepsy (JME) is the most common type of idiopathic generalized epilepsy with onset in adolescence and adulthood. During medical genetic counseling in probands with JME, aggravated epilepsy-related heredity is often detected. However, specific genetic variants of JME predisposition remain inconclusive. The use of contemporary methods of genetic analysis, particularly whole-exome and whole-genome sequencing, allows to detect, confirm and strengthen an association of any certain pathological phenotype with one or another pathogenic variant in a number of genes.Objective: to analyze the results of whole exome sequencing in patients with JME and seek for JME associations.Material and methods. The study included 7 patients with established JME diagnosis and 1 proband child without clinical signs of epilepsy. Whole exome sequencing was carried out by using MiSeq (Illumina, USA), bioinformatics analysis was performed on the Genomenal platform (Novel Software Systems, Russia).Results. Heterozygous carriage of pathogenic variants in the genes of recessive diseases was revealed: SACS, AHI1, CEP164, ANO10, RMND1, POMGNT1, FLG, ACTB. The analysis of the identified genetic variants in the patients examined showed no association with the clinical picture of the disease. Heterozygous missense mutations in CLCN2, EFHC1, JRK, ME2 genes and frameshift mutation in the CACNB4 gene were detected. Conclusion. In recent years, significant efforts were made to identify genes which predispose to JME. During our study, monogenic and/or polygenic pathogenic variants in patients with JME and a child of proband with JME were not identified. The high genetic heterogeneity of JME can explain numerous unsuccessful attempts to find genes predisposing to JME. Further research is necessary to confirm variants associated with potential JME. Advances in genomic technology can expand our understanding of the genetics of this pathology.
- 15 October 2022
- Published by IRBIS in Epilepsy and paroxysmal conditions
- Vol. 14 (3) , 254-266
Open AccessWhole-exome sequencing of patients with juvenile myoclonic epilepsy
Background. Juvenile myoclonic epilepsy (JME) is the most common type of idiopathic generalized epilepsy with onset in adolescence and adulthood. During medical genetic counseling in probands with JME, aggravated epilepsy-related heredity is often detected. However, specific genetic variants of JME predisposition remain inconclusive. The use of contemporary methods of genetic analysis, particularly whole-exome and whole-genome sequencing, allows to detect, confirm and strengthen an association of any certain pathological phenotype with one or another pathogenic variant in a number of genes.Objective: to analyze the results of whole exome sequencing in patients with JME and seek for JME associations.Material and methods. The study included 7 patients with established JME diagnosis and 1 proband child without clinical signs of epilepsy. Whole exome sequencing was carried out by using MiSeq (Illumina, USA), bioinformatics analysis was performed on the Genomenal platform (Novel Software Systems, Russia).Results. Heterozygous carriage of pathogenic variants in the genes of recessive diseases was revealed: SACS, AHI1, CEP164, ANO10, RMND1, POMGNT1, FLG, ACTB. The analysis of the identified genetic variants in the patients examined showed no association with the clinical picture of the disease. Heterozygous missense mutations in CLCN2, EFHC1, JRK, ME2 genes and frameshift mutation in the CACNB4 gene were detected. Conclusion. In recent years, significant efforts were made to identify genes which predispose to JME. During our study, monogenic and/or polygenic pathogenic variants in patients with JME and a child of proband with JME were not identified. The high genetic heterogeneity of JME can explain numerous unsuccessful attempts to find genes predisposing to JME. Further research is necessary to confirm variants associated with potential JME. Advances in genomic technology can expand our understanding of the genetics of this pathology.